MedTrace Logo

Memantine and Postoperative Pain

NCT01032759 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2016-03-14

Study results available
· View outcomes & findings →

Summary

Memantine is associated with improvement in pain relief after surgery.

Conditions

Interventions

DRUG

Memantine

20 mg, BID

DRUG

Placebo

BID

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01032759 on ClinicalTrials.gov